2008
DOI: 10.1002/art.23474
|View full text |Cite
|
Sign up to set email alerts
|

A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children

Abstract: Objective. To identify a set of clinical parameters that can predict the probability of carrying mutations in one of the genes associated with hereditary autoinflammatory syndromes.Methods. A total of 228 consecutive patients with a clinical history of periodic fever were screened for mutations in the MVK, TNFRSF1A, and MEFV genes, and detailed clinical information was collected. A diagnostic score was formulated based on univariate and multivariate analyses in genetically positive and negative patients (train… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
104
0
22

Year Published

2009
2009
2017
2017

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 167 publications
(128 citation statements)
references
References 25 publications
2
104
0
22
Order By: Relevance
“…Another class of mutations, exemplified by R92Q and P46L missense mutations, occurs in 1-5% of the general population (and for P46L, in up to 10% of a West African population) (9,10). These two variants are more likely to be functional polymorphisms thought to synergize with other abnormalities to cause a milder form of TRAPS with low penetrance (11).…”
mentioning
confidence: 99%
“…Another class of mutations, exemplified by R92Q and P46L missense mutations, occurs in 1-5% of the general population (and for P46L, in up to 10% of a West African population) (9,10). These two variants are more likely to be functional polymorphisms thought to synergize with other abnormalities to cause a milder form of TRAPS with low penetrance (11).…”
mentioning
confidence: 99%
“…Экс-пертами в области изучения АВЗ для их идентификации предложены алгоритмы диагностики, включающие клини-ческие классификационные критерии, рекомендации по лечению [15][16][17][18][19]. Разработаны также диагностический счет для определения степени риска наличия АВЗ и показания для проведения молекулярно-генетического анализа [20]. Поскольку одних клинических данных для диагностики АВЗ не всегда достаточно, современные методы генетиче-…”
Section: с о в P E м е н н а я р е в м а т о л о г и я № 3 ' 1 7 о р unclassified
“…It is not uncommon that with overlapping symptoms or with partial or atypical clinical forms that prevent a precise clinical diagnosis, the testing of disease responsible genes help to make a diagnosis. Flow charts have been developed as a guidance or screening tool to know which genes to test, 54 but testing is not recommended if there are no highly indicative symptoms, because their interpretation may not be conclusive or mutations with incomplete penetrance may be found, which usually do not require treatment.…”
Section: Molecular Analysismentioning
confidence: 99%